Michael A. Metzger, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 17,159 shares at $21.03 ($361K) on 2026-02-09, disclosed to the SEC on 2026-02-10.
Seasonal sale ($361k) by Chief Executive Officer — this insider has traded SNDX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |
| SNDX | SELL | 2025-07-18 | $140K | — | Filing → |